Search

everythinglearnresearchcommunity

for

Search:↓

The TT/DHT ratio may help identify PCOS patients with severe metabolic issues.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Recombinant thymosin β4 promotes blood vessel growth and reduces muscle damage.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

A specific group of early-stage melanocytes is reduced in vitiligo-affected skin, which may explain treatment resistance.

Testosterone therapy in transgender individuals can increase the risk of erythrocytosis.

γδ T cells are crucial for early wound healing after a skin virus infection.

Activin increases skin tumor formation, skin Tregs help hair growth, lymph-node removal doesn't improve melanoma survival, cells can revert to stem cells in wound healing, and skin bacteria produce peptides that may treat infections.

Mice with human skin protein K8 had more skin problems and cancer.

Enhancing immune response can improve cancer treatment effectiveness.

Alopecia areata in these mice is inherited, more common in young females, and can be treated with triamcinolone acetonide.

Tsc2-deficient stem cells can help understand and treat TSC-related tumors.

CD1d expression in scalp skin and hair follicles changes with the hair cycle and may help protect against microbes.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Combining DEB-BACE with chemotherapy is more effective and has fewer side effects than chemotherapy alone for treating unresectable lung squamous cell carcinoma.

TR3 is mainly found in hair follicle stem cells and may be involved in hair loss.

TCF7L2 gene polymorphism is linked to alopecia areata, but it doesn't affect the success of PRP or conventional treatments.

RCS-01 cell therapy is safe and improves skin gene expression.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Testosterone replacement therapy significantly improved sexual interest and function in HIV+ men.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Combining TCA with 5-FU is more effective and safer for treating keloids than TCA alone.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

CGF therapy may effectively treat psoriasis by reducing inflammation.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

γδ T cells are essential for wound healing after poxvirus infection.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.